Bruno Ramos-Molina, PhD

Group Leader of the Obesity, Diabetes and Metabolism Lab at the Biomedical Research Institute of Murcia (IMIB) | PI & Research Professor (Tenured)

[Bruno Ramos-Molina, PhD @Brunorm84]

🔎 We are looking for outstanding postdoctoral researchers interested in applying for the upcoming Juan de la Cierva (@AgEInves) and Sara Borrell (@SaludISCIII) fellowship calls to join the Obesity, Diabetes and Metabolism lab at @IMIB_RMurcia (Murcia,🇪🇸) under my supervision👇

[NEJM @NEJM]

Correspondence: A Liver-Targeted 𝘊𝘐𝘋𝘌𝘉 siRNA in Adults with MASLD https://t.co/0zJjyfkhih

#TLM26 | @AASLDtweets

[Bruno Ramos-Molina, PhD @Brunorm84]

Pregnane X receptor deletion induces a lean phenotype in chow-fed mice through a liver–ileum–muscle axis involving 6α-hydroxylated bile acids and Fgf15 @MolMetab
https://t.co/2EhBppxhWa

[Bruno Ramos-Molina, PhD @Brunorm84]

@NEJM Amazing results! #MASLD 🤯🤯🤯

[NEJM @NEJM]

Presented at #TLM26:

A single dose of an siRNA targeting liver expression of 𝘊𝘐𝘋𝘌𝘉 was associated with a reduction in liver fat of 58 to 80% at week 36 after treatment in persons with metabolic dysfunction–associated steatotic liver disease. Full trial results: https://t.co/gQfFsMwWG2

@AASLDtweets

[Science Magazine @ScienceMagazine]

Healthy remodeling of adipose tissue helps maintain metabolic balance and protect surrounding organs. But when this process is disrupted, it can lead to harmful cellular changes that contribute to metabolic disease and that damage nearby tissues. Although weight loss can reverse many aspects of fat-tissue dysfunction, some changes may persist.

According to a new #ScienceReview, understanding which changes are reversible and which leave lasting effects is key to helping researchers develop treatments that don’t just reduce fat mass, but also restore healthy fat-tissue function and improve metabolic resilience.

Learn more: https://t.co/kUECLBFH1C

[Bruno Ramos-Molina, PhD @Brunorm84]

Gut #microbiome profiles associated with simple liver steatosis in #MASLD @Gut_BMJ https://t.co/6ZoSOycwNE

[Bruno Ramos-Molina, PhD @Brunorm84]

Biological sex-dependent hormonal signaling and metabolomic profiles in #obesity alter tumor microenvironment and #immunotherapy outcomes @jclinicalinvest https://t.co/jaj6ycIyfu

[Bruno Ramos-Molina, PhD @Brunorm84]

Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity #obesity @JCI_insight
https://t.co/mid1Y9KOJE

[Bruno Ramos-Molina, PhD @Brunorm84]

@JuanJoseRL97 Creo que te vas a acercar bastante

[Bruno Ramos-Molina, PhD @Brunorm84]

@Cordoba_Lab @IzabelaHawro @TheEndoSociety Excellent work! Congrats to the team!!

[Bruno Ramos-Molina, PhD @Brunorm84]

@Cordoba_Lab @ajpgi @IzabelaHawro @Diabetes_UIC @ResearchDiets Congrats!

[Bruno Ramos-Molina, PhD @Brunorm84]

Furan fatty acids reprogram hepatic lipid metabolism via acyl-CoA conjugates in #obesity @ScienceAdvances https://t.co/I5jEagFgrS

[Bruno Ramos-Molina, PhD @Brunorm84]

Disrupting the PNPLA3-ABHD5 Interaction Stimulates Lipolysis and Improves PNPLA3-I148M–Associated Hepatic Steatosis #MASLD @Diabetes_ADA https://t.co/tpgtmfQejc

[Bruno Ramos-Molina, PhD @Brunorm84]

Hyperactive mTORC1 underlies sex dimorphic progression of #MASLD in mice with hepatocyte prohibitin-1 deficiency @MolMetab https://t.co/PalLi9wzy6

[Eleonora Scorletti MD, PhD @EScorletti]

The Scorletti Lab website at @HopkinsMedicine @HopkinsGIHep is now live: https://t.co/bt62QvAYm7
We are recruiting Postdoctoral Fellows to study cellular mechanisms underlying metabolic disease, aging, and cancer using iPSC-derived hepatocytes and organoids.

[Bruno Ramos-Molina, PhD @Brunorm84]

A gut microbial odd-chain fatty acid alleviates atherosclerosis in mice #microbiota #CVD @Nature
https://t.co/0iHUWaW6Lv

[Bruno Ramos-Molina, PhD @Brunorm84]

Neonatal overfeeding accelerates age-related sarcopenia and metabolic disorders through lifelong gut mucosa and microbiota programming in mice #aging #obesity @NatureComms https://t.co/FXVlaOaixn

[Bruno Ramos-Molina, PhD @Brunorm84]

@acrujeirasm @idis_research @ACIS_sergas @SaludISCIII @DrTinahones Enhorabuena!!

[Bruno Ramos-Molina, PhD @Brunorm84]

Metabolic benefits of ketohexokinase inhibition in individuals with #MASLD: a randomized placebo-controlled crossover trial @NatMetabolism
https://t.co/QSpdgPruUI

[Manuel D. Gahete @ManuelDGahete]

🔬 Postdoctoral opportunity | Juan de la Cierva 2026
The @MolHepatolGC30 is looking for a talented postdoctoral researcher to join our team.

🧬 MASLD/MASH & HCC
🧬 RNA biology & tRNA/ARSs
🧬 Splicing & RNA metabolism

📩 Interested? Send your CV + short research statement